NCT02375724 - BENEFITS OF ACLIDINIUM BROMIDE IN THE RELIEF OF COPD SYMPTOMS INCLUDING COUGH | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Aclidinium Bromide

Inhaled Aclidinium 400 μg twice per day by Eklira Genuair Inhaler

DRUG

Placebo

Inhaled dose-matched placebo, twice per day by Eklira Genuair Inhaler

Trial Locations (24)

Research Site, Berlin

Research Site, Dortmund

Research Site, Frankfurt

Research Site, Frankfurt am Main

Research Site, Hanover

Research Site, Lübeck

Research Site, Balassagyarmat

Research Site, Debrecen

Research Site, Komárom

Research Site, Nyíregyháza

Research Site, Pécs

Research Site, Százhalombatta

Research Site, Napoli

Research Site, Pisa

Research Site, Alicante

Research Site, Barcelona

Research Site, Hospitalet de Llobregat(Barcel

Research Site, Laredo

Research Site, Madrid

Research Site, Santiago(A Coruña)

Research Site, Seville

Research Site, Manchester

Research Site, Northwood

Research Site, Sidcup